`
` AO 120 (Rev. 08/10)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the U.S. District Court
`on the following
`G Trademarks or G Patents. ( G the patent action involves 35 U.S.C. § 292.):
`DOCKET NO.
`DATE FILED
`U.S. DISTRICT COURT
`
`PLAINTIFF
`
`DEFENDANT
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
`DATE INCLUDED
`
`PATENT OR
`TRADEMARK NO.
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`G Other Pleading
`G Cross Bill
`G Answer
`HOLDER OF PATENT OR TRADEMARK
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
`In the above—entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`CLERK
`
`(BY) DEPUTY CLERK
`
`DATE
`
`Copy 1—Upon initiation of action, mail this copy to Director Copy 3—Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`
`
`of Massachusetts
`
`of Massachusetts
`
`
`Save As...
`
`Reset
`
`1:23-cv-11573
`
`7/13/2023
`
`GENENTECH, INC., HOFFMANN-LA ROCHE INC., and
`CHUGAI PHARMACEUTICAL CO., LTD
`
`BIOGEN MA INC and BIO-THERA SOLUTIONS, LTD.
`
`See Addendum
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`Format m/d/yyyy
`
`4
`
`
`
`Case 1:23-cv-11573-LTS Document 2 Filed 07/13/23 Page 2 of 2
`
`U.S. Patent No.
`7,332,289
`
`7,521,052
`8,398,980
`8,512,983
`8,574,869
`8,734,800
`9,714,293
`9,902,777
`10,017,732
`10,336,983
`10,501,769
`
`10,662,237
`10,676,710
`10,744,201
`10,829,732
`10,982,003
`11,021,728
`11,078,294
`11,136,610
`11,377,678
`
`Issue Date
`February 19, 2008
`
`April 21, 2009
`March 19, 2013
`August 20, 2013
`November 5, 2013
`May 27, 2014
`July 25, 2017
`February 27, 2018
`July 10, 2018
`July 2, 2019
`December 10, 2019
`
`May 26, 2020
`June 9, 2020
`August 18, 2020
`November 10, 2020
`April 20, 2021
`June 1, 2021
`August 3, 2021
`October 5, 2021
`July 5, 2022
`
`Holder of Patent
`Chugai Pharmaceutical Co.,
`Ltd (“Chugai”)
`Chugai
`Chugai
`Genentech, Inc. (“Genentech”)
`Genentech
`Chugai
`Genentech
`Chugai
`Genentech
`HLR
`Chugai; Hoffmann-La Roche,
`Inc. (“HLR”)
`Genentech
`Genentech
`Chugai
`Genentech
`Genentech
`Chugai; HLR
`Genentech
`Chugai; HLR
`Chugai; HLR
`
`ADDENDUM
`
`